TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
ORKA

Oruka Therapeutics, Inc.

Healthcare · Biotechnology

83.30$ +1.4% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

Oruka Therapeutics, Inc. (ORKA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -88 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ORKA
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025
-59 -37 -46 -18 -42 -8.3 -7.0 -4.1 -5.3 -9.4 -11 -15 -17 -8.2 -4.8 -7.7 -19 -11 -58 -88
2.7 3.2 2.3 0.2 0.5 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1
– – – – – – – – – – – – – – – – – – – 24
9.9 54 -49 0.1 -13 -0.4 -0.5 -0.1 1.3 -0.4 0.1 0.4 0.1 -0.6 0.4 1.9 0.0 -1.7 12 -2.6
2.6 2.4 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2
-1.2 -62 21 -2.5 46 0.3 2.0 – 0.0 0.0 0.0 -16 13 3.0 0.0 0.0 0.0 0.0 -330 -97
– – – – – – – – – – – – – – – – – – – 0.0
81 122 -3.4 13 -3.9 7.3 3.9 1.1 19 8.0 34 – 5.8 3.1 6.6 48 23 – 450 170
38 23 -28 -24 0.0 -0.7 -1.1 -3.0 14 -1.4 23 -31 1.3 -2.1 1.8 41 4.3 -11 24 -15
-62 -40 -46 -20 -42 -8.3 -7.0 -4.1 -5.3 -9.4 -11 -15 -17 -8.2 -4.8 -7.7 -19 -11 -58 -88

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?